Not necessarily. They are getting very receptive to being open at the pre-competitive stage. The data are just too large and complex now for any one company to manage and figure out. Number of initiatives along these lines, but it will be slow progress for sure.
Comments
Very cool concept this whole open source science thing. But big pharma is going to put a stop on it...
Not necessarily. They are getting very receptive to being open at the pre-competitive stage. The data are just too large and complex now for any one company to manage and figure out. Number of initiatives along these lines, but it will be slow progress for sure.